Profile data is unavailable for this security.
About the company
Bajaj Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of bulk drugs and pharmaceutical products. The Company's segments include manufacturing of Bulk Drugs, and Formulation. The Company manufactures and markets Active Pharmaceutical Ingredients (APIs), Intermediates and Finished Dosage Formulations (FDFs) with focus on Vitamins, Amino Acids, Anti-Convulsants and other Finished Dosage Forms (FDFs) catering to various therapeutic segments. The Company's product portfolio consists of various APIs in the therapeutic categories of Neutraceutical (Amino Acids), Vitamins, Anti-Convulsants, Bactericidal and Bacteriostatic, Diuretic and Vasodilator, Mineral and Nutritional supplements, Bronchodilater/Anti-asthmatic and Nootropics. Its FDFs include various therapeutic segments, such as Antibiotics, Anti-Arrhythmia, Anti-Convulsants, Anti-Diabetes, Anti-Platelets, Vitamins and its Derivatives and Anti-Hypertensive.
- Revenue in INR (TTM)6.91bn
- Net income in INR569.04m
- Incorporated1993
- Employees1.05k
- LocationBajaj Healthcare Ltd202-204Faiz-E-Qutbi, 375,Narshi Natha StreetTHANE 400604IndiaIND
- Phone+91 2 240177400
- Fax+91 2 266177458
- Websitehttp://www.bajajhealth.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beta Drugs Ltd | -100.00bn | -100.00bn | 6.06bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 57.91 | -- | 356.78 | -- | -- | -- |
| Lincoln Pharmaceuticals Ltd | 5.00bn | 713.61m | 6.61bn | 1.25k | 9.27 | -- | 8.25 | 1.32 | 35.62 | 35.62 | 249.77 | -- | -- | -- | -- | -- | -- | 13.45 | -- | 17.08 | 52.37 | 50.55 | 14.26 | 13.25 | -- | 56.07 | -- | -- | 11.30 | 5.26 | 11.46 | 19.79 | 20.91 | 4.56 |
| Vimta Labs Ltd | 3.00bn | 487.64m | 6.65bn | 1.27k | 13.88 | 2.58 | 8.77 | 2.21 | 21.65 | 21.65 | 133.37 | 116.38 | 0.9588 | 3.90 | 3.89 | 2,359,890.00 | 15.56 | 8.88 | 18.82 | 11.18 | 76.17 | 71.34 | 16.23 | 10.45 | 2.27 | 25.64 | 0.0638 | 15.89 | 32.09 | 12.58 | 93.09 | 31.30 | -0.5906 | -- |
| Medico Remedies Ltd | -100.00bn | -100.00bn | 6.68bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.41 | -- | 7.20 | -- | 24.67 | -- | 2.43 | -- | -- | -- | -- | -1.12 | 17.33 | 88.68 | 24.60 | -4.35 | -- |
| Panacea Biotec Ltd | 4.72bn | 12.17bn | 6.96bn | 1.06k | 0.5729 | -- | 0.5671 | 1.48 | 198.47 | 198.47 | 77.11 | -- | -- | -- | -- | 4,458,904.00 | -- | 9.69 | -- | 17.46 | 43.98 | 55.39 | 257.85 | 24.67 | -- | -2.27 | -- | 0.00 | 5.83 | 3.46 | 837.06 | -- | -12.14 | -- |
| Zota Health Care Ltd | 1.34bn | -41.49m | 7.47bn | 297.00 | -- | -- | 135.59 | 5.56 | -1.65 | -1.65 | 53.61 | -- | -- | -- | -- | 4,526,751.00 | -- | 5.37 | -- | 7.05 | 36.48 | 30.73 | -3.09 | 4.88 | -- | -1.62 | -- | 67.63 | 22.85 | 12.88 | 4,364.05 | 9.96 | 11.07 | 0.9805 |
| Jagsonpal Pharmaceuticals Ltd | 2.25bn | 204.13m | 7.80bn | -- | 38.24 | -- | 35.83 | 3.47 | 7.79 | 7.79 | 85.90 | -- | -- | -- | -- | -- | -- | 5.39 | -- | 6.85 | 60.36 | 58.22 | 9.08 | 4.60 | -- | 98.92 | -- | 38.85 | 15.77 | 8.44 | 10.54 | 9.71 | -28.93 | 109.13 |
| Medicamen Biotech Ltd | 1.25bn | 137.00m | 7.81bn | 357.00 | 56.06 | -- | 39.10 | 6.25 | 11.01 | 11.01 | 100.53 | -- | -- | -- | -- | 3,500,164.00 | -- | 8.02 | -- | 11.97 | 51.22 | 33.66 | 10.97 | 10.62 | -- | 6.12 | -- | 9.01 | 2.42 | 6.96 | 22.82 | 23.62 | 29.99 | 0.00 |
| Bliss GVS Pharma Ltd | 7.34bn | 871.47m | 7.83bn | 750.00 | 9.15 | -- | 6.82 | 1.07 | 8.21 | 8.21 | 69.11 | -- | -- | -- | -- | 9,784,959.00 | -- | 7.11 | -- | 9.87 | 48.31 | 36.87 | 13.18 | 10.68 | -- | 16.38 | -- | 11.79 | 29.50 | 12.91 | -78.04 | -6.36 | -6.52 | -3.58 |
| NGL Fine-Chem Ltd | 2.82bn | -817.29m | 8.26bn | 329.00 | -- | -- | -- | 2.93 | -132.29 | -132.29 | 457.23 | -- | -- | -- | -- | 8,580,666.00 | -- | 17.96 | -- | 24.18 | 13.77 | 48.76 | -28.95 | 14.83 | -- | -63.53 | -- | 2.93 | 23.08 | 24.42 | -12.03 | 27.37 | 22.93 | -- |
| Bajaj Healthcare Ltd | 6.91bn | 569.04m | 9.11bn | 1.05k | 16.02 | -- | 11.24 | 1.32 | 20.62 | 20.62 | 250.20 | -- | -- | -- | -- | 6,564,269.00 | -- | 11.38 | -- | 19.70 | 26.47 | 25.65 | 8.24 | 8.64 | -- | 4.44 | -- | -- | 3.49 | 24.14 | -14.11 | 55.61 | 50.96 | -- |
| Themis Medicare Ltd | 3.54bn | 584.45m | 10.89bn | 1.15k | 18.66 | -- | 15.89 | 3.08 | 63.41 | 63.41 | 384.11 | -- | -- | -- | -- | 3,091,841.00 | -- | 7.88 | -- | 13.03 | 66.86 | 59.46 | 16.51 | 10.95 | -- | -- | -- | 6.39 | 71.07 | 11.78 | 104.13 | 35.49 | 30.56 | -- |
| Suven Life Sciences Ltd | 151.49m | -1.11bn | 10.97bn | 117.00 | -- | -- | -- | 72.41 | -6.67 | -6.67 | 0.9369 | -- | -- | -- | -- | 1,294,812.00 | -- | -9.45 | -- | -10.92 | 76.64 | 65.15 | -735.49 | -19.84 | -- | -360.85 | -- | -- | -12.12 | -53.49 | -69.08 | -- | -8.33 | -- |
| RPG Life Sciences Limited | 4.98bn | 648.10m | 11.80bn | 1.17k | 18.21 | -- | 14.72 | 2.37 | 39.20 | 39.20 | 301.24 | -- | -- | -- | -- | 4,275,708.00 | -- | 10.28 | -- | 14.95 | 66.36 | 61.70 | 13.01 | 7.69 | -- | 265.31 | -- | 27.43 | 13.11 | 7.49 | 28.70 | 33.61 | -15.58 | 27.94 |
| TTK Health Care Ltd | 7.04bn | 284.73m | 12.22bn | 2.59k | 42.90 | -- | 29.14 | 1.74 | 20.16 | 448.26 | 498.06 | -- | -- | -- | -- | 2,718,869.00 | -- | 5.08 | -- | 8.37 | 51.26 | 56.70 | 4.05 | 3.76 | -- | 1.52 | -- | 34.31 | 25.88 | 2.57 | -49.68 | -0.2463 | 3.72 | 14.87 |
| Holder | Shares | % Held |
|---|---|---|
| Motilal Oswal Asset Management Co. Ltd.as of 28 Feb 2023 | 88.00 | 0.00% |
